Lupus erythematosus
MONDO:0004670An autoimmune, connective tissue chronic inflammatory disorder affecting the skin, joints, kidneys, lungs, heart, and the peripheral blood cells. It is more commonly seen in women than men. Variants include discoid and systemic lupus erythematosus.
Also known as: lupus, lupus erythematosus
582 clinical trials for this condition and its sub-types, 39 tagged with Lupus erythematosus itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Sub-types of Lupus erythematosus
-
Systemic lupus erythematosus 516 trials · 522 incl. sub-types
10 sub-types
- Pediatric systemic lupus erythematosus 16 trials
- Central nervous system lupus 2 trials
- Neonatal lupus erythematosus 1 trial
- Autosomal systemic lupus erythematosus type 16 0 trials
- Bullous systemic lupus erythematosus 0 trials
- Systemic lupus erythematosus 17 0 trials
- Systemic lupus erythematosus 18 0 trials
- Systemic lupus erythematosus related to C1QA 0 trials
- Systemic lupus erythematosus related to C1S 0 trials
- Systemic lupus erythematosus related to C4A 0 trials
-
Cutaneous lupus erythematosus 38 trials · 46 incl. sub-types
4 sub-types
- Chronic cutaneous lupus erythematosus 3 trials · 23 incl. sub-types Sub-types →
- Subacute cutaneous lupus erythematosus 11 trials
- Rowell syndrome 0 trials
- Bullous systemic lupus erythematosus 0 trials
-
Drug-induced lupus erythematosus 1 trial
Most studied deeper sub-types
-
Experimental Donor-Cell therapy takes aim at tough autoimmune diseases
Disease control OngoingThis early-stage study tests a therapy called SC291, made from donor immune cells, in 7 people with severe lupus or vasculitis that hasn't improved with standard treatments. The goal is to see if it is safe and tolerable, and to get a first look at whether it can control the dise…
Phase 1 • Sponsor: Sana Biotechnology • Aim: Disease control
Last updated Jun 27, 2026 07:59 UTC
-
Gene-Edited cell therapy for lupus trial pulled before it started
Disease control CancelledThis early-stage study aimed to test a single infusion of CB-010, a CRISPR-edited CAR-T cell therapy made from donor cells, in people with severe lupus that did not respond to standard treatments. The trial was withdrawn before enrolling any participants, so no results are availa…
Phase 1 • Sponsor: Caribou Biosciences, Inc. • Aim: Disease control
Last updated Jun 26, 2026 18:51 UTC
-
Fatigue study seeks to unravel mystery of exhaustion
Knowledge-focused OngoingThis study aims to better understand fatigue by comparing people who have felt tired for more than a month with those who are not fatigued. Researchers will use questionnaires, physical tests, and optional brain scans to identify different types of fatigue. The goal is to gather …
Sponsor: National Center for Complementary and Integrative Health (NCCIH) • Aim: Knowledge-focused
Last updated Aug 26, 2026 00:00 UTC
-
New study tests if help with housing, food, or transport can cut missed arthritis appointments
Knowledge-focused OngoingThis study looks at whether helping people with inflammatory arthritis address social needs—like food, housing, or transportation—can reduce missed doctor visits. About 100 adults with conditions like rheumatoid arthritis or lupus who have missed appointments in the past year wil…
Sponsor: Brigham and Women's Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:54 UTC